logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

SABCS 2019 – HER2+ breast cancer: trastuzumab emtansine fails to top paclitaxel plus trastuzumab

Findings from the phase 2 ATEMPT study.